Can a zoom class help seniors avoid diabetes? new study tests telehealth prevention program

NCT ID NCT05166785

First seen Oct 31, 2025 · Last updated Jun 23, 2026 · Updated 33 times

Summary

This study compares a telehealth version of the Diabetes Prevention Program (DPP) tailored for older adults to the standard in-person program. About 238 seniors aged 65+ with prediabetes will be randomly assigned to either 16 weekly sessions plus monthly support via video or in person. The goal is to see if the online version works as well for weight loss and blood sugar control, potentially making prevention easier for older adults to access.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PRE-DIABETES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • NYU Langone Health

    New York, New York, 10016, United States

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Diabetes Prevention Program (DPP) tailored for older adults

What this could lead to

If successful, this could show that a telehealth version of the diabetes prevention program works as well as in-person classes for older adults, making it easier for seniors to access and stick with the program.

What could go wrong

This is a relatively small study (238 people) comparing two delivery methods, not testing a new drug. The results may not apply to all older adults, and adherence or weight loss could differ between groups.

Conditions

The condition(s) this trial relates to.

glucose intolerance prediabetes syndrome type 2 diabetes mellitus prevention target

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.